Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
scientific article published on 6 March 2014
Author/s
author: Joan Carles Galcerán, John D Hainsworth, Karim Fizazi, Mary-Ellen Taplin, Fred Saad, Howard I. Scher, Tomasz M Beer, Celestia Higano, Eric J Small, Peter F.A. Mulders, Christopher Logothetis
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.